Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer. Axell-House, D., Wurster, S., Jiang, Y., Kyvernitakis, A., Lewis, R., Tarrand, J., Raad, I., & Kontoyiannis, D. Journal of Fungi, 2021. Cited By :6 \par Cited By :6 \par Export Date: 20 November 2022 \par Export Date: 20 November 2022
doi  bibtex   
@article{axell-house.etal_2021a,
  title = {Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer},
  author = {{Axell-House}, D.B. and Wurster, S. and Jiang, Y. and Kyvernitakis, A. and Lewis, R.E. and Tarrand, J.J. and Raad, I.I. and Kontoyiannis, D.P.},
  year = {2021},
  journal = {Journal of Fungi},
  volume = {7},
  number = {3},
  doi = {10.3390/jof7030217},
  note = {Cited By :6
\par
Cited By :6
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/2TUPYQXL/Axell-House et al_2021_Breakthrough mucormycosis developing on mucorales-active antifungals portrays a.pdf}
}

Downloads: 0